Jianping Zhou, PA
Physician Assistant · Pasadena, MDNPI 1881636744
Payments from drug & device makers
Across 127 payments — averaging $32.53 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$1K
- AstraZeneca$360
- Novo Nordisk$326
- Lilly USA, LLC$320
- Dexcom, Inc.$237
- GSK$224
- plus $2K from 17 others
What the payments were for
- Food & beverage$4,117100%
- Education$140%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 40 | $1,131 |
| AstraZeneca | 9 | $360 |
| Novo Nordisk | 11 | $326 |
| Lilly USA, LLC | 9 | $320 |
| Dexcom, Inc. | 4 | $237 |
| GSK | 6 | $224 |
| Pfizer | 11 | $223 |
| Boehringer Ingelheim | 5 | $185 |
| Bayer | 5 | $177 |
| Exact Sciences | 6 | $143 |
| Corcept Therapeutics | 2 | $137 |
| Merck | 1 | $111 |
| Astellas Pharma US Inc | 4 | $99 |
| Axsome Therapeutics, Inc. | 1 | $96 |
| Cequr Corporation | 1 | $81 |
| Amgen | 3 | $56 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $52 |
| Johnson & Johnson | 2 | $50 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 2 | $39 |
| Neuronetics, Inc. | 1 | $26 |
| Abbott | 1 | $25 |
| Medtronic | 1 | $17 |
| Life Molecular Imaging Ltd | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$4,131 in reported general payments places this provider in the 90th percentile of 2,567 physician assistant providers in Maryland.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 57 | $59,918 |
| JardianceEmpagliflozin | 27 | $37,160 |
| EliquisApixaban | 38 | $29,505 |
| TrulicityDulaglutide | 13 | $25,316 |
| JanuviaSitagliptin Phosphate | 18 | $24,737 |
| Toujeo SolostarInsulin Glargine,hum.Rec.Anlog | 20 | $21,657 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 23 | $18,360 |
| TradjentaLinagliptin | 13 | $14,963 |
| Anoro ElliptaUmeclidinium Brm/Vilanterol Tr | 18 | $8,027 |
| Praluent PenAlirocumab | 14 | $6,487 |
| Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog | 13 | $5,109 |
| Novolog FlexpenInsulin Aspart | 22 | $5,011 |
| Atorvastatin Calcium | 274 | $4,243 |
| Metoprolol Succinate | 170 | $3,126 |
| SymbicortBudesonide/Formoterol Fumarate | 11 | $2,598 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic | $326 | $59,91857 claims |
| Boehringer IngelheimJardiance, Tradjenta | $185 | $52,12440 claims |
| PfizerEliquis | $223 | $29,50538 claims |
| GSKTrelegy Ellipta, Anoro Ellipta | $224 | $26,38641 claims |
| Lilly USA, LLCTrulicity | $320 | $25,31613 claims |
| MerckJanuvia | $111 | $24,73718 claims |
| AstraZenecaSymbicort | $360 | $2,59811 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 2,567 physician assistant providers in Maryland.
Other physician assistant in Pasadena
- Margaret JoyceTowson$220K
- Kara CossisBaltimore$177K
- Michael RitmillerOwings Mills$92K
- Garland JamesSilver Spring$86K
- Melissa BearekmanBaltimore$81K
- Brittany YerkesSalisbury$81K
- Bruce SmithBaltimore$63K
- Shannon MarriottBaltimore$38K
- Amy CollierTimonium$29K
- Hannah JohnsonNottingham$27K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.